Plain-English translation of NCT06887413 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a device called CAT RX that removes blood clots during emergency heart attack treatment. When someone has a heart attack caused by a blocked artery in the front of the heart, doctors perform an emergency procedure to open the artery. The CAT RX device is being tested to see whether removing the clot first—before opening the artery—improves heart function and leads to better outcomes for patients.
Heart attacks from blood clots can cause lasting damage to heart muscle. Researchers want to know whether removing the clot as part of the emergency treatment can prevent some of this damage and help patients recover better.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the new CAT RX clot removal device or standard emergency treatment during your heart attack procedure. After the procedure, you will have a heart scan (MRI) within 3 to 5 days to measure how much heart damage occurred. You will then have follow-up visits or phone calls at 30 days and 12 months after your procedure to check on your recovery and overall health.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Italy